Methodological Quality of Studies of Endstage Renal Disease in Lupus Nephritis, 1970 to 2015

被引:0
|
作者
Tektonidou, Maria G. [1 ,2 ]
Ward, Michael M. [3 ]
机构
[1] Natl & Kapodistrian Univ Athens, Sch Med, Joint Acad Rheumatol Program, Rheumatol Unit,Dept Internal Med 1, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Sch Med, Joint Acad Rheumatol Program, Rheumatol,Dept Internal Med 1, Athens, Greece
[3] NIAMS, NIH, Bldg 10 CRC,Room 4-339,10 Ctr Dr, Bethesda, MD 20892 USA
关键词
LUPUS NEPHRITIS; ENDSTAGE RENAL DISEASE; METHODOLOGICAL QUALITY; OBSERVATIONAL STUDIES; CLINICAL TRIALS; TRIALS; BIAS; RISK;
D O I
10.3899/jrheum.160546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To examine trends in methodological quality of studies of endstage renal disease risk in lupus nephritis, 1970-2015. Methods. We assessed quality using the Newcastle-Ottawa scale for observational studies, and the Cochrane Collaboration's risk-of-bias tool for trials. Results. In observational studies, description of enrollment criteria was high but decreased over time. Adequacy of followup was low but improved. Inception cohorts and community-based studies were uncommon. Trials had low risk of bias in blinding and selective outcome reporting but most had unclear risks in sequence generation and allocation concealment. Conclusion. Methodological quality was mixed, with limited improvement over time.
引用
收藏
页码:626 / 630
页数:5
相关论文
共 50 条
  • [21] RENAL TUBULAR ACIDIFYING DEFECT IN TUBULOINTERSTITIAL DISEASE OF LUPUS NEPHRITIS
    FENNELL, J
    SCHWARTZ, MM
    BIDANI, AK
    LEWIS, EJ
    [J]. KIDNEY INTERNATIONAL, 1981, 19 (01) : 125 - 125
  • [22] PREDICTORS OF END STAGE RENAL DISEASE IN THE RENAL BIOPSY PROVEN LUPUS NEPHRITIS
    Duran, E.
    Yildirim, T.
    Kalyoncu, U.
    Taghiyeva, A.
    Saglam, E. Arzu
    Uner, M.
    Bilgin, E.
    Jabrayilov, J.
    Bolek, E. C.
    Onal, C.
    Farisogullari, B.
    Koc, N. S.
    Yardimci, G. K.
    Girgin, S.
    Ayan, G.
    Ozsoy, Z.
    Uzun, G. Sandal
    Kilic, L.
    Yilmaz, S. R.
    Akdogan, A.
    Bilgen, S. A.
    Karadag, O.
    Kiraz, S.
    Altun, B.
    Ertenli, A. I.
    Arici, M.
    Erdem, Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 648 - 649
  • [23] Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis
    Schiffer, Lena
    Bethunaickan, Ramalingam
    Ramanujam, Meera
    Huang, Weiqing
    Schiffer, Mario
    Tao, Haiou
    Madaio, Michael M.
    Bottinger, Erwin P.
    Davidson, Anne
    [J]. JOURNAL OF IMMUNOLOGY, 2008, 180 (03): : 1938 - 1947
  • [24] Disease Specific Quality of Life in Patients with Lupus Nephritis.
    Mok, Chi Chiu
    Toloza, Sergio
    Goker, Berna
    Clarke, Ann E.
    Navarra, S.
    Wallace, Daniel J.
    Weisman, Michael H.
    Jolly, Meenakshi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S736 - S737
  • [25] Disease-specific quality of life in patients with lupus nephritis
    Jolly, M.
    Toloza, S.
    Goker, B.
    Clarke, A. E.
    Navarra, S. V.
    Wallace, D.
    Weisman, M.
    Mok, C. C.
    [J]. LUPUS, 2018, 27 (02) : 257 - 264
  • [26] BTK Inhibition Ameliorates Renal Disease in Spontaneous Murine Lupus Nephritis
    Chalmers, Samantha
    Glynn, Elizabeth
    Panzenbeck, Mark
    Pelletier, Josephine
    Bosanac, Todd
    Khalil, Sara
    der, EVan
    Herlitz, Leal
    Webb, Deborah
    Nabozny, Gerald
    Fine, Jay S.
    Klein, Elliott
    Souza, Donald
    Putterman, Chaim
    Ramanujam, Meera
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [27] A Comparative Study of Lupus Nephritis Class II and IgA Nephropathy: Renal Disease Other Than Lupus Nephritis in Systemic Lupus Erythematosus Patients
    Kang, Eun Song
    Hong, Seokchan
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2904 - 2906
  • [28] Association of Renal Arteriosclerosis With Atherosclerotic Cardiovascular Disease Risk in Lupus Nephritis
    Garg, Shivani
    Raval, Amish N.
    Hansen, Karen E.
    Zhong, Weixiong
    Huang, Yabing
    Smith, Maureen
    Panzer, Sarah E.
    Bartels, Christie M.
    [J]. ARTHRITIS CARE & RESEARCH, 2022, 74 (07) : 1105 - 1112
  • [29] MYELOPEROXIDASE SUPPRESSES THE DEVELOPMENT OF AUTOIMMUNITY AND RENAL DISEASE IN EXPERIMENTAL LUPUS NEPHRITIS
    Odobasic, D.
    Muljadi, R. C. M.
    Summers, S. A.
    Kitching, A. R.
    Holdsworth, S. R.
    [J]. NEPHROLOGY, 2014, 19 : 58 - 58
  • [30] LUPUS NEPHRITIS IN MALES : PROGNOSTIC FACTORS FOR END STAGE RENAL DISEASE
    Melek, Kharroubi
    Raja, Aouidia
    Hanene, Gaid
    Mouna, Jerbi
    Soumaya, Chargui
    Hayet, Kaaroud
    Hedri, Hafedh
    Mondher, Ounissi
    Fethi, Ben Hmida
    Rim, Goucha
    Taib, Ben Abdallah
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33